Intraoperative immunohistochemistry staining of sentinel nodes in breast cancer: Clinical and economical implications

Breast

Volumn 17, Issue 4, 2008, Pages 372-375

  Holm, Marianne ^a   Paaschburg, Birgitte ^a   Balslev, Eva ^a   Axelsson, Christen Kirk ^a   Willemoe, Gro Linno ^a   Flyger, Henrik Lavlund ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Breast cancer; Cost analysis; Intraoperative immunohistochemistry; Late positive rate; Re operation; Sentinel node

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; FROZEN SECTION; HEALTH ECONOMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MASTECTOMY; MICROMETASTASIS; OPERATION DURATION; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY;

EID: 48649095046     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2008.01.005     Document Type: Article

References (18)

1. Veronesi U., Paganelli G., Viale G., Luini A., Zurrida S., Galimberti V., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 6 (Aug 7, 2003) 546-553
2. Blanchard D.K., Donohue J.H., Reynolds C., and Grant C.S. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138 5 (May 2003) 482-487
3. Husen M., Paaschburg B., and Flyger H.L. Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 15 5 (Oct 2006) 620-628
4. Badgwell B.D., Povoski S.P., Abdessalam S.F., Young D.C., Farra W.B., Walker M.J., et al. Patterns of recurrence after sentinel lymph node biopsy for breast cancer. Ann Surg Oncol 10 4 (May 2003) 376-380
5. Lyman G.H., Giuliano A.E., Somerfield M.R., Benson III A.B., Bodurka D.C., Burstein H.J., et al. ASCO Guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 30 (Oct 20, 2005) 7703-7720
6. Nährig J.M., Richter T., Kuhn W., Avril N., Flatau B., Kowolik J., et al. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry. Breast J 9 4 (Jul-Aug 2003) 277-281
7. Johnston E.I., Beach R.A., Waldrop S.M., Lawson D., and Cohen C. Rapid intraoperative immunohistochemical evaluation of sentinel lymph nodes for metastatic breast carcinoma. Appl Immunohistochem Mol Morphol 14 1 (Mar 2006) 57-62
8. Lee I.K., Lee H.D., Jeong J., Park B.W., Jung W., Hong S.W., et al. Intraoperative examination of sentinel lymph nodes by immunohistochemical staining in patients with breast cancer. Eur J Surg Oncol 32 4 (May 2006) 405-409
9. Cserni G., Gregori D., Merletti F., Sapino A., Mano M.P., Ponti A., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg 91 10 (Oct 2004) 1245-1252
10. Mullenix P.S., Brown T.A., Meyers M.O., Giles L.R., Sigurdson E.R., Buraas M.C., et al. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer. Am J Surg 189 5 (May 2005) 606-609
11. Wong S.L., Chao C., Edwards M.J., Simpson D., and McMasters K.M. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am J Surg 182 4 (Oct 2001) 330-334
12. Chagpar A., Middleton L.P., Sahin A.A., Meric-Bernstam F., Kuerer H.M., Feig B.W., et al. Review, clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 103 8 (Apr 15, 2005) 1581-1586
13. Celebioglu F., Sylvan M., Perbeck L., Bergkvist L., and Frisell J. Intraoperative sentinel lymph node examination by frozen section, immunoistochemistry and imprint cytology during breast surgery - a prospective study. Eur J Cancer 42 5 (Mar 2006) 617-620
14. Rydén L., Chebil G., Sjöström L., Pawlowski R., and Jönsson P.-E. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastasis and isolated tumour cells: analysis of 174 patients after SLN biopsy. Eur J Surg Oncol 33 1 (Feb 2007) 33-38
15. Klevesath M.B., Bobrow L.G., Pinder S.E., and Purushotham A.D. The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer. Br. J Cancer 92 12 (Jun 2005) 2201-2205
16. Sundhedsstyrelsen. Mammografiscreeningen i Fyns Amt 1993-1997. En medicinsk teknologivurdering. English summary. Puljeprojekter 4 1 (2004). www.cemtv.dk ISBN electronic 87-91437-31-8
17. Viale G., Maiorano E., Pruneri G., Mastropasqua M.G., Valentini S., Galimberti V., et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 241 2 (Feb 2005) 319-325
18. Dabbs D.J., Fung M., Landsittel D., McManus K., and Johnson R. Sentinel lymph node micrometastasis as a predictor of axillary tumour burden. Breast J 10 2 (Mar-Apr 2004) 101-105